Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

NCT02595398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveitis
Uveitis, Posterior
Uveitis, Anterior
Uveitis, Intermediate
Panuveitis

Interventions

DRUG: 4mg CLS-TA Suprachoriodal Injection
DRUG: Sham Procedure

Sponsor

Clearside Biomedical, Inc.